Tuberculosis Trial, Recruiting NCT06526689 Sponsor: University of Oxford Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06526689
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old
  • You live in or near London or Oxford and can stay in the area for the whole study period
  • You are willing to sign a consent form agreeing to take part
  • You are happy for the research team to look at your NHS health records, medical history, blood test results, and X-rays
  • You are able and willing to follow all the study requirements, in the opinion of the research team

For Groups A and B only:

  • You have already been screened for TB through the NHS (including a blood test called an IGRA, and possibly a chest X-ray)
  • You have had close contact with someone who has been confirmed as having infectious TB within the last 12 weeks

Who may not be able to join:

  • You have taken part in another research study involving an experimental treatment in the last 30 days, or plan to during this trial
  • You have a history of severe allergic reactions (anaphylaxis) or an allergy that could be made worse by the study procedures
  • You have poorly controlled asthma or another breathing condition, an active cancer (other than certain minor skin or cervical conditions), a bleeding disorder, or issues with drug or alcohol use
  • You have a significant condition affecting your immune system, such as an autoimmune disease or HIV
  • You have previously been diagnosed with or treated for TB disease or latent (inactive) TB infection
  • There is any current sign — from symptoms, scans, or blood tests — that you may have active TB disease right now
  • You have previously received any experimental TB vaccine or an inhaled (aerosolised) BCG vaccine
  • You have an abnormal result on a breathing test called spirometry (confirm with trial site)
  • You are currently using steroid medication taken by mouth, inhaled, or injected into the body, or have used them for more than 14 days in the past 6 months (steroid creams or ointments are generally acceptable), or you are using other medicines that suppress the immune system
  • You have taken antibiotics in the past 4 weeks
  • You have received immunoglobulins or any blood products in the past 3 months
  • You have received a live vaccine in the past 28 days
  • You have received any other (non-live) vaccine in the past 14 days
  • You are pregnant or planning to become pregnant during the study
  • You have any other condition or health concern that the research team believes could put you at risk, affect your participation, or affect the study results

For Group C only:

  • You have previously had close contact with a TB case, or have previously been contacted by TB services for contact tracing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Helen McShane, PhD, University of Oxford

Phone: +44 (0)1865 611385

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 August 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The immunological response after recent M.tb exposure measured as the differentials of innate immune cells in the blood and sputum.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov